Head of Clinical Development

reputed company Therapeutics is unifying AI and biotech to discover novel and breakthrough treatments for patients with severe and devastating conditions. reputed company was founded on groundbreaking molecular ML research and since has established itself as the industry leader in AI for small molecule drug discovery. reputed company of accomplished biotech leaders and expert drug hunters joins forces with deep learning researchers and software engineers who are pioneering predictive and reputed company technologies for molecules.

reputed company has created the industry's most advanced molecular AI platform reputed company GEMS (reputed company Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery and to reputed company the discovery of novel first-in-class and best-in-class small molecule drugs for challenging and/or undruggable targets. 

The company has leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, reputed company has signed AI-focused platform collaborations with major pharmaceutical companies, including most recently Incyte Corporation (Feb 2025) and reputed company (Sept 2024).

We raised a $200M series B in August 2023, and have raised over $300M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, reputed company, Fidelity, Radical Ventures, NVentures (reputed company's VC arm), reputed company, and reputed company Ventures. 

reputed company is headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.